PE20080712A1 - Tratamiento de fibrosis cistica con antibioticos por via de suministro de un torbellinador - Google Patents

Tratamiento de fibrosis cistica con antibioticos por via de suministro de un torbellinador

Info

Publication number
PE20080712A1
PE20080712A1 PE2007000681A PE2007000681A PE20080712A1 PE 20080712 A1 PE20080712 A1 PE 20080712A1 PE 2007000681 A PE2007000681 A PE 2007000681A PE 2007000681 A PE2007000681 A PE 2007000681A PE 20080712 A1 PE20080712 A1 PE 20080712A1
Authority
PE
Peru
Prior art keywords
treatment
dextrose
injection
fibrosis
cyystic
Prior art date
Application number
PE2007000681A
Other languages
English (en)
Inventor
Hanumantharao Tatapudy
Syed M Shad
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38657254&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PE20080712(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of PE20080712A1 publication Critical patent/PE20080712A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A61K31/431—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems containing further heterocyclic rings, e.g. ticarcillin, azlocillin, oxacillin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/65—Tetracyclines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dispersion Chemistry (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

SE REFIERE A UNA COMPOSICION EN AEROSOL LIQUIDA QUE COMPRENDE UNA DROGA ANTIBIOTICA TAL COMO ZOSYN(PIPERACICLINA Y TAZOBACTAM), PIPERACILINA, TAZOBACTAM O TYGACIL (TIGLECICLINA); Y UN DILUYENTE QUE COMPRENDE AGUA ESTERIL PARA INYECCION, 0.9% DE CLORURO DE SODIO PARA INYECCION, 5% DE DEXTROSA PARA INYECCION; 5% DE DEXTROSA, 5% DE DEXTROSA, ENTRE OTROS, EL CUAL SE COLOCA EN EL DEPOSITO DEL SISTEMA DE SUMINISTRO DE DROGA EN AEROSOL SWIRLER, QUE SE CONECTA A UNA FUENTE DE GAS PRESURIZADA, EN DONDE EL TAMANO DE LAS PARTICULAS OBTENIDAS ES DE AL MENOS 90% DE LAS GOTAS DE 1 A 3 MICRONES O MENOS. DICHA COMPOSICION ES UTIL PARA EL TRATAMIENTO DE ENFERMEDADES RESPIRATORIAS TAL COMO LA FIBROSIS CISTICA
PE2007000681A 2006-06-07 2007-06-01 Tratamiento de fibrosis cistica con antibioticos por via de suministro de un torbellinador PE20080712A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US81167106P 2006-06-07 2006-06-07

Publications (1)

Publication Number Publication Date
PE20080712A1 true PE20080712A1 (es) 2008-05-22

Family

ID=38657254

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2007000681A PE20080712A1 (es) 2006-06-07 2007-06-01 Tratamiento de fibrosis cistica con antibioticos por via de suministro de un torbellinador

Country Status (4)

Country Link
AR (1) AR061263A1 (es)
PE (1) PE20080712A1 (es)
TW (1) TW200815003A (es)
WO (1) WO2007145866A1 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102641249A (zh) * 2012-05-06 2012-08-22 江苏奥赛康药业股份有限公司 一种替加环素组合物的制备方法
US8476425B1 (en) 2012-09-27 2013-07-02 Cubist Pharmaceuticals, Inc. Tazobactam arginine compositions
US9320740B2 (en) 2013-03-15 2016-04-26 Merck Sharp & Dohme Corp. Ceftolozane-tazobactam pharmaceutical compositions
US9872906B2 (en) 2013-03-15 2018-01-23 Merck Sharp & Dohme Corp. Ceftolozane antibiotic compositions
KR102226197B1 (ko) 2013-03-15 2021-03-11 머크 샤프 앤드 돔 코포레이션 세프톨로잔 항균성 조성물
WO2015035376A2 (en) 2013-09-09 2015-03-12 Calixa Therapeutics, Inc. Treating infections with ceftolozane/tazobactam in subjects having impaired renal function
US20150094293A1 (en) 2013-09-27 2015-04-02 Calixa Therapeutics, Inc. Solid forms of ceftolozane
US9566399B1 (en) 2015-04-14 2017-02-14 Clempharma LLC Deep lung alveolar aerosol targeted drug delivery

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5508269A (en) * 1994-10-19 1996-04-16 Pathogenesis Corporation Aminoglycoside formulation for aerosolization
US5611332A (en) * 1995-03-22 1997-03-18 Bono; Michael Aerosol inhalation device containing a rain-off chamber
WO2003075889A1 (en) * 2002-03-05 2003-09-18 Transave, Inc. An inhalation system for prevention and treatment of intracellular infections

Also Published As

Publication number Publication date
TW200815003A (en) 2008-04-01
WO2007145866A1 (en) 2007-12-21
AR061263A1 (es) 2008-08-13

Similar Documents

Publication Publication Date Title
PE20080712A1 (es) Tratamiento de fibrosis cistica con antibioticos por via de suministro de un torbellinador
PE20130589A1 (es) Composiciones y metodos para suministro al sistema nervioso central de arilsulfatasa a
ES2525530T3 (es) Sistemas de administración oral de liberación controlada
ES2650689T3 (es) Administración de agentes terapéuticos al sistema nervioso central
BRPI0707845B8 (pt) positivo de envio de droga
PE20131324A1 (es) Formulacion subcutanea de anticuerpo anti-her2
AR062059A1 (es) Espuma farmaceutica con acido graso
PE20110291A1 (es) Combinacion farmaceutica de 3-(3-dimetilamino-1-etil-2-metil-propil)-fenol y un antiepileptico
MX9301823A (es) Composicion para el suministro de liberacion controlado de un agente biologicamente activo.
BRPI0603087A (pt) dispositivo de aplicação de fármacos de injeção de jato livre de agulha
BRPI0515982B8 (pt) medicamento em forma de microemulsão e sistema de aplicação para a administração percutânea de substâncias medicamentosas
AR070025A1 (es) Uso de derivados de 1-amino-alquilciclohexano para el tratamiento del tinnitus coclear y composicion farmaceutica
NZ603345A (en) Stabilized ophthalmic galactomannan formulations
AR080368A1 (es) Disoluciones acuosas transparentes de acetonido de fluocinolona para el tratamiento de la inflamacion de oido
PE20141539A1 (es) Una nueva composicion terapeutica que contiene apomorfina como principio activo
PE20110711A1 (es) Tratamiento de trastornos cognitivos con (r)-7-cloro-n-(quinuclidin-3-il)benzo[b]tiofeno-2-carboxamida y sales farmaceuticamente aceptables de la misma
CL2004000899A1 (es) Composicion farmaceutica que contiene la sal sodica de telmisartan y un agente diuretico y procedimiento de preparacion.
PE20080329A1 (es) Tratamiento de fibrosis cistica con antibioticos por via de una droga en aerosol
ATE507818T1 (de) Orale verabreichung eines calcitonins
BR112013027010A2 (pt) método de produzir substâncias com gás supersaturado, dispositivo para sua entrega trasdérmica, e seus usos
ATE539761T1 (de) Mittel für injektionszwecke mit einem antibiotikum und das mittel enthaltende lösung zur injektion
ATE350024T1 (de) Flüssige zubereitung enthaltend tobramycin
AR096875A1 (es) Composiciones de hialuronano de gran elasticidad y sus usos
BR112023000631A2 (pt) Dispositivo de administração de agente, sistema de administração de agente e método para administrar um agente
CL2010001594A1 (es) Uso de nifurtimox para preparar un medicamento útil en el tratamiento de enfermedades causadas por trichomonadida.

Legal Events

Date Code Title Description
FA Abandonment or withdrawal